… 2 shows the results of the univariate analysis for these prognostic factors. In our patients age
did not appear as a significant prognostic factor, different cut-points (ages) were evaluated. …

The relation between estrogen receptors (ER) and/or progesterone receptors (PgR) and
some clinical factors such as tumor size, axillary node involvement, histological tumor grade, …

… Conclusions regarding a lack of significance of prognostic factors should not be made without
considerable caution. The estrogen receptor was not a significant prognostic factor in the …

… Various possible prognostic factors are compared with the receptor and nodal status of the
patient group in Table 1. There were significantly more large tumors in the node-positive com …

… be considered as an additional risk factor of ovarian malignancy [2]. More evidence on OC
hormonedependence was presented when estrogens (ER) and progesterone re ceptors (PR) …

… progesterone receptor as a significant prognostic factor next to clinical stage. Estrogen
receptor had no significant prognostic … of gestagen treatment and progesterone receptor status …

… type, malignancy grading, and estrogen (ER) as well as progesterone (PgR) receptors. …
receptor,16 the progesterone receptor is widely acknowledged as a relevant prognostic factor.7'8 …

… The prognostic factors determining tumor progression and ultimately the patients' fate …
transforming growth factor-beta 1 (TGF-β1) is a strongly independent negative prognostic marker …

… Tumor size, grade and lymph node status are the most important prognostic factors for …
prognosis seen in ER - PR - patients could be because of associated adverse prognostic factors. …

… prognosis, among them 15%–25% died in 5 years. It is still unknown whether integrating
estrogen receptor (ER) and progesterone … This study was to investigate the prognostic value of …